Endocrine Technology Overview

  • Founded
  • 2002

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • (Cancelled)
  • Latest Deal Amount
  • $20M

Endocrine Technology General Information


Owner and operator of a biotechnology company. The company focuses on filing New patent applications for the therapy of diabetes and its complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 326 Livingston Street
  • New York, NY 11217
  • United States
+1 (718) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endocrine Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC $20M Cancelled Startup
2. Grant 00.00 00.00 Completed Startup
1. Angel (individual) $2.2M $2.2M Completed Startup
To view Endocrine Technology’s complete valuation and funding history, request access »

Endocrine Technology Executive Team (1)

Name Title Board Seat Contact Info
Kumarpal Shah MD Founder, Owner & President, Business Development
To view Endocrine Technology’s complete executive team members history, request access »